Skip to main content

Table 1 Clinical characteristics of the study population

From: Diffusion-weighted MRI and 18F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma

Characteristics All (n = 54) pCR (n = 10) Non-pCR (n = 36) P
  n (%) n (%) n (%)  
Age     0.67
 Mean(range) 63 (48,75) 63 (55,70) 62 (48,75)  
 ≤ 60 15 (27.8) 2 (20.0) 12 (33.3)  
 > 60 39 (72.2) 8 (80.0) 24 (66.7)  
Sex     0.50
 Male 49 (90.7) 10 (100.0) 31 (86.1)  
 Female 5 (9.3) 0 (0.0) 5 (13.9)  
Tumor location     0.28
 Proximal 8 (14.8) 2 (20.0) 5 (13.8)  
 Middle 16 (29.6) 1 (10.0) 13 (36.2)  
 Distal 30 (55.5) 7 (70.0) 18 (50.0)  
Length, cm     0.47
 Mean (range) 6 (3,10) 6 (4,9) 6 (3,10)  
 ≤ 6 cm 38 (70.4) 6 (60.0) 28 (77.8)  
 > 6 cm 16 (29.6) 4 (40.0) 8 (22.2)  
Clinical T stage     0.39
 T1-2 2 (3.7) 1 (10.0) 1 (2.8)  
 T3-4 52 (96.3) 9 (90.0) 35 (97.2)  
Clinical N stage     0.61
 N negative 3 (48.1) 1 (60.0) 2 (50.0)  
 N positive 51 (51.9) 9 (40.0) 34 (50.0)  
Clinical stage     0.91
 II 2 (3.7) 1 (10.0) 1 (2.8)  
 III 52 (96.3) 9 (90.0) 35 (97.2)  
Chemotherapy     
 Weekly 32 (59.3) 4 (40.0) 21 (58.3) 0.50
 3-weekly 22 (40.7) 6 (60.0) 15 (41.7)